Please reload

Follow Us

May 11, 2016

Abstract

Background

Few studies on spatial patterns or secular trends in human leishmanias have been conducted in Morocco. This study aimed to examine spatial patterns and trends associated with the human leishmaniasis incidence rate (HLIR) at the province/prefecture lev...

Please reload

  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

October 6, 2017

Please reload

Recent Posts
Search By Tags
Featured Posts

CDC Video showing N.Fowleri

July 21, 2017

1/4
Please reload

Archive
Please reload

 Impavido® (miltefosine) is an FDA-approved treatment for cutaneous,  mucosal and visceral leishmaniasis in patients 12 years of age and older. PLEASE SEE FULL PRESCRIBING INFO